The BiosearchTech Blog

Biosearch Technologies Launches New GMP Production Facility and Successfully Certifies to ISO 13485:2003

Posted on Thu, Apr 18, 2013 @ 08:00 AM

Biosearch Technologies, Inc. (Biosearch), a leader in the development and manufacture of GMP grade oligonucleotides, announced today the relocation of its GMP manufacturing process into a new, state-of-the-art GMP production facility in Novato, California.  The 30,000 square foot facility was developed to further expand processes and controls relevant to medical device and molecular diagnostic customers.

Read More

Topics: Announcement, Molecular Diagnostics

Biosearch Technologies Responds To China Influenza H7N9 Outbreak By Providing H7N9 Detection Panel

Posted on Mon, Apr 15, 2013 @ 06:00 AM

Biosearch Technologies, Inc. (Biosearch) announced today that the company has implemented a rapid response to the current outbreak of Avian Influenza Virus A (H7N9) in China.  Biosearch is ready to provide to the scientific community on-demand, rapid synthesis of real-time qPCR probes and primers composing the H7N9 detection panel recently developed and published on 8 April by the World Health Organization (WHO) Collaborating Center for Reference and Research on Influenza in Beijing, China.  WHO lists FAM-BHQ® probes as crucial reagents in their protocol named, “Real-time RT-PCR Protocol for the Detection of A(H7N9) Influenza Virus,” which is available for download at:

Read More

Topics: Announcement, Product Information, Biodefense

Biosearch Technologies, UMDNJ Stellaris® Probe Alliance - NextGen Gene Expression™, SNP FISH™, and iceFISH™ in Research and Clinical Applications

Posted on Mon, Mar 18, 2013 @ 08:43 AM

Biosearch Technologies, Inc. (Biosearch), a leading supplier of sophisticated oligonucleotide components to the rapidly growing molecular diagnostics industry, today announced that the company has acquired exclusive worldwide rights to continuing Stellaris® RNA FISH based inventions from the University of Medicine and Dentistry of New Jersey (UMDNJ).  In addition to single molecule detection of mRNA, lncRNA, and viral RNAs, Stellaris based methods have been extended to directly and quantitatively detect chromosomal diseases caused by translocations and aberrant splice junctions,(intron chromosomal expression – iceFISH™) and single-nucleotide polymorphisms (SNPs or SNP FISH™).  Biosearch’s exclusive access to Stellaris probe design is offered complimentary at www.biosearchtech.com/stellarisdesigner.

Read More

Topics: Announcement, RNA FISH

Biosearch Technologies Announces Acquisition of European Companies DNA Technology and VitraBio

Posted on Thu, Feb 21, 2013 @ 06:00 AM


Biosearch Technologies, Inc. (Biosearch), a leading supplier of sophisticated, custom-manufactured oligonucleotides and specialty amidites and CPGs to the research and diagnostics markets, announced today that it has acquired the oligonucleotide manufacturing division of the Danish company DNA Technology A/S (DNA Technology) and German CPG manufacturer VitraBio GmbH (VitraBio).

Read More

Topics: Announcement

Biosearch Technologies Launches Catalogued Stellaris™ RNA FISH Assays

Posted on Mon, Jun 18, 2012 @ 08:08 AM

Biosearch Technologies, Inc. (Biosearch), a leading supplier of sophisticated oligonucleotide components to the rapidly growing molecular diagnostics industry, today announced that the company has launched catalogued assays for Stellaris™ RNA FISH. These assays fall into three groups – well characterized RNA targets (“foundation genes”) suitable for use as positive controls, oncogenes, and key mRNAs in the hypusine pathway.

Read More

Topics: Announcement, RNA FISH

Biosearch Technologies Appoints Uniscience as Brazilian Distributor

Posted on Tue, May 22, 2012 @ 08:16 AM

Biosearch Technologies, Inc. (Biosearch), a leading supplier of sophisticated oligonucleotide components to the rapidly growing molecular diagnostics industry, today announced that Uniscience is the new distributor authorized to sell, market, and support Biosearch’s inventoried and custom products in the country of Brazil. 

Read More

Topics: Announcement

Biosearch Technologies Launches Improved RNA FISH Design Software

Posted on Mon, Mar 19, 2012 @ 07:54 AM

Biosearch Technologies, Inc. (Biosearch), a leading supplier of sophisticated oligonucleotide components to the rapidly growing molecular diagnostics industry, today announced that the company has launched an improved Stellaris™ Probe Designer. The online, RNA FISH design software provides scientists with a means to design Stellaris RNA FISH probe sets against any mRNA or long noncoding RNA.

Read More

Topics: Announcement, RNA FISH

Blogging about Stellaris™ RNA FISH at Singlemoleculefish.com

Posted on Mon, Oct 24, 2011 @ 12:24 PM

Biosearch Technologies is starting a new sister blog at singlemoleculefish.com where all articles will focus on topics related to Stellaris RNA FISH. We will be doing our best to provide as many resources as possible to help you understand the potential of this new RNA FISH technology.  You can keep up with the latest by attending AMP's 2011 Annual Meeting at Grapevine, TX. At this molecular pathology conference, Biosearch will be conducting a Stellaris FISH workshop on Weds, November 16 at 1PM in room Grapevine 2.

Read More

Topics: Announcement, RNA FISH

Special Summer Offer from Biosearch

Posted on Mon, Jun 13, 2011 @ 08:49 AM

Despite the unusually brisk May/June weather in California, Biosearch is welcoming the summer with a new promotion to heat things up.  Customers now have a chance to receive a $25 Amazon Gift Card and a chance to win an Apple iPad 2 by placing an online order of $750 or more at Biosearchtech.com.  For each additional $750+ online order, customers can receive another $25 Amazon Gift Card and another entry in our iPad 2 raffle.  Visit Biosearch’s promotions webpage to learn more details.

Read More

Topics: Announcement

Biosearch Technologies and Intelligent Medical Devices, Inc. (IMDx) Finalize cGMP Oligo Supply and Licensing Agreements for Molecular Diagnostic Testing (IVD) Products

Posted on Tue, Mar 15, 2011 @ 10:01 AM

Biosearch Technologies, Inc. (Biosearch), a leading supplier of sophisticated oligonucleotide components to the rapidly growing molecular diagnostics industry, and IMDx (privately held), a developer and manufacturer of innovative, clinically impactful molecular test solutions, today announced that Biosearch has licensed access to the BHQ®, CAL Fluor® and Quasar® patents to IMDx.  In addition, Biosearch will manufacture cGMP oligonucleotides for IMDx for use in human in-vitro diagnostics.

Read More

Topics: Announcement, Molecular Diagnostics, Real-time PCR

Subscribe to our blog

About Biosearch Technologies

As the inventor of the BHQ dyes, Biosearch Technologies synthesizes sophisticated oligos for real time qPCR, molecular diagnostics, and more!  Visit our home page to view our products and services.

Posts by popularity

Follow @BiosearchTech on Twitter

Become a Fan on Facebook!